Debra Hoppensteadt Selected Research

Hemophilia A (Haemophilia)

4/2017	Recombinant Factor VIIa-Mediated Activation of Prothrombin Complex Concentrates.
9/2014	Comparative Biochemical and Functional Studies on a Branded Human Recombinant Factor VIIa and a Biosimilar Equivalent Product.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Debra Hoppensteadt Research Topics

Disease

30	Inflammation (Inflammations) 01/2023 - 07/2004
20	Thrombosis (Thrombus) 01/2021 - 03/2002
17	Hemorrhage 01/2022 - 06/2007
14	Sepsis (Septicemia) 01/2021 - 05/2002
11	Atrial Fibrillation 01/2023 - 10/2008
11	Disseminated Intravascular Coagulation 01/2021 - 11/2011
10	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 07/2004
8	Chronic Renal Insufficiency 01/2020 - 06/2013
7	Thrombocytopenia (Thrombopenia) 01/2021 - 03/2002
6	Pulmonary Embolism 01/2023 - 01/2021
6	Venous Thromboembolism 01/2019 - 10/2008
5	Osteoarthritis 01/2021 - 05/2018
4	Pain (Aches) 04/2022 - 07/2019
4	Bipolar Disorder (Manic Depressive Psychosis) 10/2020 - 01/2018
4	Infections 01/2020 - 06/2007
4	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 01/2009
3	Critical Illness (Critically Ill) 01/2021 - 04/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 07/2015
3	Joint Diseases (Joint Disease) 01/2020 - 07/2016
3	Stroke (Strokes) 12/2018 - 03/2003
3	Varicose Veins (Varicose Vein) 10/2016 - 10/2015
3	Thrombophilia 07/2013 - 01/2005
3	Premature Obstetric Labor (Premature Labor) 01/2010 - 06/2007
2	Lymphoma (Lymphomas) 01/2021 - 01/2020
2	Chronic Disease (Chronic Diseases) 01/2021 - 12/2018
2	Neuroinflammatory Diseases 10/2020 - 01/2018
2	Heart Failure 12/2018 - 03/2018
2	Hemophilia A (Haemophilia) 04/2017 - 09/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2017 - 02/2016
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2017 - 05/2002
2	Burns 07/2013 - 10/2007
2	Myocardial Infarction 01/2013 - 03/2003
2	Necrosis 01/2009 - 05/2002
2	Pre-Eclampsia (Preeclampsia) 12/2008 - 09/2007

Drug/Important Bio-Agent (IBA)

44	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2009
14	Heparin (Liquaemin)FDA LinkGeneric 09/2013 - 03/2002
11	AnticoagulantsIBA 01/2022 - 03/2002
10	fibrin fragment D (D-dimer)IBA 01/2023 - 11/2011
10	Hemostatics (Antihemorrhagics)IBA 01/2022 - 10/2008
10	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 11/2011
8	Thrombin FDA Link 01/2020 - 07/2004
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2014
7	ThrombomodulinIBA 01/2020 - 11/2011
7	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2019 - 05/2002
6	C-Reactive ProteinIBA 01/2023 - 07/2004
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2005
5	Plasminogen Activator Inhibitor 1IBA 01/2023 - 01/2005
5	AntibodiesIBA 01/2022 - 03/2002
5	CytokinesIBA 01/2021 - 03/2014
5	EnzymesIBA 01/2020 - 07/2015
5	Protein CIBA 01/2019 - 05/2002
4	CollagenIBA 01/2023 - 07/2018
4	PRT064445IBA 01/2022 - 01/2020
4	ImmunosorbentsIBA 01/2020 - 07/2015
4	Interleukin-10 (Interleukin 10)IBA 01/2019 - 03/2014
4	AntithrombinsIBA 12/2018 - 05/2002
4	Thromboplastin (Tissue Factor)IBA 10/2014 - 10/2008
3	von Willebrand FactorIBA 01/2023 - 07/2015
3	GlycosaminoglycansIBA 01/2023 - 01/2022
3	RivaroxabanIBA 01/2022 - 10/2008
3	apixabanIBA 01/2022 - 09/2013
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2020 - 01/2009
3	ProcalcitoninIBA 01/2020 - 03/2015
3	antithrombin III-protease complexIBA 01/2020 - 10/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 09/2012
3	Angiopoietin-2IBA 01/2019 - 11/2018
3	InterleukinsIBA 01/2019 - 10/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2009
3	lubricinIBA 01/2019 - 01/2018
3	Warfarin (Coumadin)FDA LinkGeneric 10/2018 - 10/2008
3	recombinant FVIIa (rFVIIa)FDA Link 04/2017 - 04/2010
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2015 - 11/2011
3	plasma protein Z (protein Z)IBA 09/2008 - 06/2007
2	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2023 - 10/2007
2	AntidotesIBA 01/2022 - 01/2022
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2020 - 01/2018
2	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 10/2020 - 01/2018
2	OsteopontinIBA 01/2020 - 01/2019
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 07/2016
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 11/2018
2	prothrombin fragment 1.2IBA 01/2020 - 07/2013
2	Nucleosomes (Nucleosome)IBA 01/2019 - 10/2018
2	CDAA (Randox)IBA 01/2019 - 10/2016
2	Interleukin-8 (Interleukin 8)IBA 01/2019 - 10/2016
2	FibrinIBA 12/2018 - 10/2015
2	CD40 Ligand (CD40L)IBA 07/2018 - 01/2008
2	C-PeptideIBA 04/2017 - 02/2016
2	LeptinIBA 04/2017 - 02/2016
2	Insulin (Novolin)FDA Link 04/2017 - 02/2016
2	Phosphopyruvate Hydratase (Enolase)IBA 06/2013 - 11/2011
2	Lipocalin-2IBA 06/2013 - 11/2011
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 03/2012 - 08/2009
2	argatroban (MPQA)FDA Link 04/2010 - 03/2002
2	Enoxaparin (Lovenox)FDA LinkGeneric 10/2009 - 10/2008

Therapy/Procedure

11	Renal Dialysis (Hemodialysis) 01/2020 - 07/2004
6	Arthroplasty 01/2021 - 04/2016
5	Therapeutics 04/2022 - 03/2002
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2019 - 04/2010
2	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2021 - 05/2018
1	Glycemic Control 01/2023